PR NEWS Logo
Home
PR NewsWire
NewsWire Today
MarketWire
Submit Your Feeds
Business News
•
MarketWire
• Vernalis Announces Successful Completion of CCP-07 Pivotal Single-Dose Comparative Bioavailability Study
Vernalis Announces Successful Completion of CCP-07 Pivotal Single-Dose Comparative Bioavailability Study
Vernalis Announces Successful Completion of CCP-07 Pivotal Single-Dose Comparative Bioavailability Study
WINNERSH, UNITED KINGDOM--(Marketwired - Dec 21, 2015) - Vernalis plc (LSE: VER) (OTC PINK: VNLPY)
View More :
http://www.marketwired.com/mw/release.do?id=2083625&sourceType=3
Releted News by marketwire
Vernalis Announces Successful Completion of CCP-07 Pivotal Single-Dose Comparative Bioavailability Study